Erik Roy Hillesland, et al v. Glenmark Pharmaceuticals, Inc. USA, et al

[DO NOT PUBLISH]
In the
United States Court of Appeals
For the Eleventh Circuit
____________________
No. 23-11047
Non-Argument Calendar
____________________
IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY
LITIGATION.
9:20-md-02924-RLR
___________________________________________________
ERIK ROY HILLESLAND,
CHANMEIKA HILL,
Interested Parties-Appellants,
versus
GLENMARK PHARMACEUTICALS, INC. USA,
MARLENE GOLDENBERG,
APOTEX CORP.,
MICHAEL MCCANDLESS,
USCA11 Case: 23-11047 Document: 28-1 Date Filed: 11/09/2023 Page: 1 of 2

-- 1 of 2 --

2 Opinion of the Court 23-11047
BRAD ALDRIDGE, et al.,
Defendants-Appellees.
____________________
Appeal from the United States District Court
for the Southern District of Florida
D.C. Docket No. 9:20-md-02924-RLR
____________________
Before W ILSON, J ILL PRYOR , and GRANT, Circuit Judges.
PER CURIAM:
Upon review of the record and the response to the jurisdic-
tional questions, this appeal is DISMISSED for lack of jurisdiction.
Appellant lacks standing to bring this appeal because there is no
evidence that he is, or ever was, a plaintiff in this action, and there
is no indication that the district court has ever entered an appeala-
ble order that caused him injury. See Wolff v. Cash 4 Titles, 351 F.3d
1348, 1353-54 (11th Cir. 2003); Mickles on behalf of herself v. Country
Club, Inc., 887 F.3d 1270, 1278 (11th Cir. 2018).
USCA11 Case: 23-11047 Document: 28-1 Date Filed: 11/09/2023 Page: 2 of 2

-- 2 of 2 --